Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,021,048
-
Total 13F shares
-
27,764,899
-
Share change
-
+1,115,798
-
Total reported value
-
$891,509,724
-
Put/Call ratio
-
57%
-
Price per share
-
$32.11
-
Number of holders
-
145
-
Value change
-
+$36,642,722
-
Number of buys
-
85
-
Number of sells
-
51
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock (SRPT) as of Q3 2015
As of 30 Sep 2015,
Sarepta Therapeutics, Inc. - Common Stock (SRPT) was held by
145 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,764,899 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, COLUMBIA WANGER ASSET MANAGEMENT LLC, FMR LLC, BlackRock Fund Advisors, STATE STREET CORP, D. E. Shaw & Co., Inc., BlackRock Institutional Trust Company, N.A., CITADEL ADVISORS LLC, and Point72 Asset Management, L.P..
This page lists
145
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.